5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.03▲ | 1.03▲ | 1.03▲ | 1.02▲ | 0.90▲ |
MA10 | 1.04▲ | 1.04▲ | 1.04▲ | 0.94▲ | 0.80▲ |
MA20 | 1.04▲ | 1.04▲ | 1.02▲ | 0.93▲ | 0.68▲ |
MA50 | 1.02▲ | 0.98▲ | 0.94▲ | 0.81▲ | 0.68▲ |
MA100 | 0.97▲ | 0.92▲ | 0.93▲ | 0.67▲ | 1.26▼ |
MA200 | 0.90▲ | 0.92▲ | 0.89▲ | 0.66▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | -0.004▼ | -0.004▼ | 0.006▲ | 0.055▲ |
RSI | 53.528▲ | 56.131▲ | 58.209▲ | 58.211▲ | 64.983▲ |
STOCH | 38.889 | 47.222 | 47.222 | 78.995 | 53.835 |
WILL %R | -33.333 | -33.333 | -33.333 | -19.713▲ | -37.000 |
CCI | 13.283 | -0.889 | 15.909 | 110.967▲ | 106.870▲ |
Thursday, May 01, 2025 05:31 AM
ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system, oncology, and ophthalmology indications, today ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.03 | 1.055 | 1.01 | 1.03 | 124,222 |
30/04/25 | 1.04 | 1.06 | 1.00 | 1.06 | 190,992 |
29/04/25 | 1.005 | 1.05 | 1.005 | 1.03 | 135,274 |
28/04/25 | 1.00 | 1.06 | 0.9201 | 1.00 | 260,666 |
25/04/25 | 0.92 | 1.01 | 0.88 | 0.9765 | 205,096 |
24/04/25 | 0.86 | 0.9357 | 0.85 | 0.911 | 120,293 |
23/04/25 | 0.82 | 0.876 | 0.806 | 0.876 | 124,894 |
22/04/25 | 0.86 | 0.8884 | 0.8207 | 0.8315 | 161,604 |
21/04/25 | 0.855 | 0.8963 | 0.82 | 0.8729 | 177,564 |
17/04/25 | 0.99 | 0.99 | 0.85 | 0.855 | 226,517 |
|
|
||||
|
|
||||
|
|